Meeting
2023 ASCO Annual Meeting
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
Authors
Edward Christopher Dee
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
Edward Christopher Dee , Alexander G Goglia , Nishwant Swami , Bastien Nguyen , Helen Y Hougen , Anwar Khan , Amar Upadhyaya Kishan , Sanoj Punnen , Paul L. Nguyen , Brandon A Mahal , Mohamed Alshalalfa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Castrate-Resistant
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5067)
DOI
10.1200/JCO.2023.41.16_suppl.5067
Abstract #
5067
Poster Bd #
161
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.
First Author: Rahul Raj Aggarwal
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in patients with prostate cancer with liver metastases.
First Author: Crystal Casado
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.
First Author: Liat Hammer